KX1-004 T1812
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
KX1-004, a potential protective drug for NIHL, is an effective small molecule inhibitor of Src-PTK.
CAS nr:
518058-84-9
Purity:
98%
Molecular Weight:
284,29
SMILES:
c1cc(cc(c1)O)CNC(=O)c1cc2c([nH]1)ccc(c2)F
Formula:
C16H13FN2O2
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis
Target:
Src,Src
